TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35449008

Group type: EXPERIMENTAL
Intervention: STRONG programme (≥6 weekly sessions with patient education, motivational and pharmaceutical support)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: STRONG programme
Number of subjects: 42

Group type: COMPARATOR
Intervention: Usual care (standard care)
Number of subjects: 42
Study: 36383389

Group type: EXPERIMENTAL
Intervention: 1-day Nordic hamstring exercise training (n = 16)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 2-day Nordic hamstring exercise training (n = 15)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (n = 14)
Number of subjects: 45
Study: 33780423

Group type: EXPERIMENTAL
Intervention: NeuroEPO (1 mL, at a concentration of 1 mg/mL) administered intranasally once a week for 5 weeks
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo administered intranasally once a week for 5 weeks
Number of subjects: 26
Study: 32188427

Group type: EXPERIMENTAL
Intervention: Poor knowledge regarding hepatitis
Number of subjects: 504

Group type: EXPERIMENTAL
Intervention: Unhygienic sanitary practices
Number of subjects: 504

Group type: EXPERIMENTAL
Intervention: Unhygienic practices related to drinking water
Number of subjects: 504

Group type: EXPERIMENTAL
Intervention: Residing in urban areas
Number of subjects: 504

Group type: EXPERIMENTAL
Intervention: Lower family income
Number of subjects: 504
Study: 35353167

Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 314

Group type: COMPARATOR
Intervention: IVCY
Number of subjects: 314
Study: 33468072

Group type: EXPERIMENTAL
Intervention: Safer conception methods (SCM)
Number of subjects: 389

Group type: EXPERIMENTAL
Intervention: Modern contraceptive use
Number of subjects: 389
Study: 32220524

Group type: EXPERIMENTAL
Intervention: Ketamine sedation with local anesthesia
Number of subjects: 47

Group type: COMPARATOR
Intervention: Ketamine sedation without local anesthesia
Number of subjects: 47
Study: 33663737

Group type: EXPERIMENTAL
Intervention: Lower Dose Edoxaban Regimen (LDER) - 30 mg once daily (dose reduced to 15 mg in selective patients)
Number of subjects: 14014

Group type: COMPARATOR
Intervention: Higher Dose Edoxaban Regimen (HDER) - 60 mg once daily (dose reduced to 30 mg in selective patients)
Number of subjects: 14014

Group type: EXPERIMENTAL
Intervention: Lower Dose Edoxaban Regimen (LDER)
Number of subjects: 14014
Study: 32403113

Group type: EXPERIMENTAL
Intervention: Topical corticosteroids
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: UVA1
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: PUVA
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Intralesional triamcinolone acetonide
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: First-line therapy
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Second-line therapy
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Third-line therapy
Number of subjects: 61
Study: 35699953

Group type: EXPERIMENTAL
Intervention: HPVCF + usual care
Number of subjects: 375

Group type: COMPARATOR
Intervention: usual care only
Number of subjects: 375
Study: 33757440

Group type: EXPERIMENTAL
Intervention: Neoadjuvant FOLFIRINOX chemotherapy (8 cycles) followed by surgery without adjuvant treatment (arm A)
Number of subjects: 368

Group type: COMPARATOR
Intervention: Neoadjuvant gemcitabine with hypofractionated radiotherapy (36 Gy in 15 fractions) during the second cycle, followed by surgery and 4 cycles of adjuvant gemcitabine (arm B)
Number of subjects: 368

Group type: EXPERIMENTAL
Intervention: Neoadjuvant FOLFIRINOX chemotherapy
Number of subjects: 368

Group type: COMPARATOR
Intervention: Neoadjuvant gemcitabine with hypofractionated radiotherapy
Number of subjects: 368
Study: 35320365

Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 316

Group type: COMPARATOR
Intervention: Medical/lifestyle intervention
Number of subjects: 316
Study: 32899447

Group type: EXPERIMENTAL
Intervention: Vitamin C supplementation (1000 mg daily) during the first six weeks of training.
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Vitamin C supplementation (1000 mg daily) during the second six weeks of training.
Number of subjects: 15

Group type: COMPARATOR
Intervention: Training without vitamin C supplementation (first six weeks).
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Training with vitamin C supplementation (last six weeks).
Number of subjects: 15
Study: 35508695

Group type: EXPERIMENTAL
Intervention: AZA-7
Number of subjects: 187

Group type: COMPARATOR
Intervention: AZA-5
Number of subjects: 187
Study: 34500184

Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 592

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 592

Group type: EXPERIMENTAL
Intervention: Additional mood-stabilizing treatment
Number of subjects: 592
Study: 32113882

Group type: EXPERIMENTAL
Intervention: Autonomous exercise plan
Number of subjects: 69
Study: 34725773

Group type: EXPERIMENTAL
Intervention: Nutrition only (NUTR, n=16)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Nutrition plus exercise (NUTR+EX, n=21)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Exercise only (EX, n=19)
Number of subjects: 56
Study: 33237672

Group type: COMPARATOR
Intervention: Randomized Controlled Trials (RCTs)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Non-Randomized Trials
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Overall Clinical Trials
Number of subjects: 23

Group type: COMPARATOR
Intervention: Q1 Journals
Number of subjects: 23

Group type: COMPARATOR
Intervention: Q2 and Q3 Journals
Number of subjects: 23

Group type: COMPARATOR
Intervention: Last 2 Decades
Number of subjects: 23
Study: 34701692

Group type: EXPERIMENTAL
Intervention: Group B (experimental group) - auto-positioning with LINAC and SGRT system
Number of subjects: 40

Group type: COMPARATOR
Intervention: Group A (control group) - manual alignment based on skin marking
Number of subjects: 40
Study: 36189646

Group type: EXPERIMENTAL
Intervention: Oral extended-release nifedipine 30 mg every 24 hours
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study: 35896614

Group type: EXPERIMENTAL
Intervention: Micro enemas delivered by the squeeze-tube method
Number of subjects: 20

Group type: COMPARATOR
Intervention: Micro enemas delivered by the catheter method
Number of subjects: 20
Study: 34212461

Group type: EXPERIMENTAL
Intervention: Non-Violent Resistance adapted for MID (NVR-MID)
Number of subjects: 124
Study: 34861125

Group type: EXPERIMENTAL
Intervention: Guided mindfulness meditation (postoperative days 0-3)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Guided mindfulness meditation
Number of subjects: 45
Study: 34961950

Group type: EXPERIMENTAL
Intervention: Ticagrelor 90 mg twice daily
Number of subjects: 250

Group type: COMPARATOR
Intervention: Aspirin 81 mg twice daily
Number of subjects: 250
Study: 32139222

Group type: EXPERIMENTAL
Intervention: High DAPT score (≥2)
Number of subjects: 11289

Group type: COMPARATOR
Intervention: Low DAPT score (<2)
Number of subjects: 11289

Group type: EXPERIMENTAL
Intervention: Ticagrelor monotherapy
Number of subjects: 11289

Group type: COMPARATOR
Intervention: Aspirin monotherapy
Number of subjects: 11289
Study: 35948866

Group type: EXPERIMENTAL
Intervention: SES-sensitive implementation strategy with additional face-to-face guidance by GP nurses
Number of subjects: 0

Group type: COMPARATOR
Intervention: All-SES implementation strategy
Number of subjects: 0
Study: 32750538

Group type: EXPERIMENTAL
Intervention: Azithromycin MDA
Number of subjects: 293
Study: 36260469

Group type: EXPERIMENTAL
Intervention: Silorane resin composite
Number of subjects: 192

Group type: COMPARATOR
Intervention: Glass ionomer cement (GIC)
Number of subjects: 192
Study: 33825030

Group type: EXPERIMENTAL
Intervention: FFP2/N95 mask
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Surgical mask
Number of subjects: 13

Group type: COMPARATOR
Intervention: No mask (control)
Number of subjects: 13
Study: 34958123

Group type: EXPERIMENTAL
Intervention: 40 mg b.i.d. enoxaparin
Number of subjects: 183

Group type: COMPARATOR
Intervention: 40 mg o.d. enoxaparin
Number of subjects: 183
Study: 34434546

Group type: EXPERIMENTAL
Intervention: Synbiotic supplementation
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 32286883

Group type: EXPERIMENTAL
Intervention: BiOSS stent
Number of subjects: 0

Group type: COMPARATOR
Intervention: Regular drug-eluting stent
Number of subjects: 0
Study: 34045137

Group type: EXPERIMENTAL
Intervention: Asymmetrical polyethylene insert
Number of subjects: 33

Group type: COMPARATOR
Intervention: Symmetrical polyethylene insert
Number of subjects: 33
Study: 34081712

Group type: EXPERIMENTAL
Intervention: Self-affirmation intervention during the first meeting with a caseworker
Number of subjects: 174
Study: 36457363

Group type: EXPERIMENTAL
Intervention: Cognitive multisensory rehabilitation (CMR) for 6 weeks followed by 6 weeks of standard of care (no therapy) at home
Number of subjects: 299000

Group type: COMPARATOR
Intervention: Standard of care (no therapy) for 6 weeks followed by 6 weeks of CMR
Number of subjects: 299000
Study: 32482335

Group type: EXPERIMENTAL
Intervention: sweet taste moisturizing gel
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: acid taste with Japanese apricot extract moisturizing gel
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Japanese apricot scent moisturizing gel
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: acid taste with citric acid moisturizing gel
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: tasteless and odorless moisturizing gel
Number of subjects: 56

Group type: COMPARATOR
Intervention: control (no gel administered)
Number of subjects: 56
Study: 33566432

Group type: EXPERIMENTAL
Intervention: Imiquimod 3.75%
Number of subjects: 9

Group type: COMPARATOR
Intervention: MAL-PDT (5-aminolaevulinic acid)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 9
Study: 35110310

Group type: EXPERIMENTAL
Intervention: Advanced Hybrid Closed Loop (AHCL) system (MiniMed 670G version 4.0)
Number of subjects: 124

Group type: COMPARATOR
Intervention: MDI plus IS‐CGM
Number of subjects: 124
Study: 33639517

Group type: EXPERIMENTAL
Intervention: Auricular point acupressure treatment (acupressure points with Cowherb seeds)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham auricular therapy (acupressure points without Cowherb seeds)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Auricular point acupressure treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham auricular therapy
Number of subjects: 60
Study: 32289190

Group type: EXPERIMENTAL
Intervention: guselkumab
Number of subjects: 130

Group type: COMPARATOR
Intervention: adalimumab
Number of subjects: 130
Study: 35958172

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (1,000 IU/day for children < 1 year; 2,000 IU/day for children 1-17 years)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control (standard of care)
Number of subjects: 45
Study: 34215606

Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine (TCM) treatment, specific intervention details not provided.
Number of subjects: 0
Study: 36121242

Group type: EXPERIMENTAL
Intervention: Self-expanding (SE) Evolut PRO/PRO+
Number of subjects: 2241

Group type: COMPARATOR
Intervention: Balloon-expandable (BE) Sapien 3 ULTRA
Number of subjects: 2241
Study: 33054825

Group type: EXPERIMENTAL
Intervention: Five-session manual-based group intervention for siblings and parents of children with neurodevelopmental disorders.
Number of subjects: 288

Group type: COMPARATOR
Intervention: 12-week waitlist control group.
Number of subjects: 288
Study: 33539268

Group type: EXPERIMENTAL
Intervention: Ultra-Long-Toss (ULT)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Straight-Line Long-Toss (SLT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Comparison of ULT and SLT
Number of subjects: 24
Study: 34151734

Group type: EXPERIMENTAL
Intervention: POST intervention (personalized Survivorship Care Plan)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 200
Study: 32807537

Group type: EXPERIMENTAL
Intervention: Modified Bilateral Clamshell Thoracotomy (MCT)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Left Anterolateral Thoracotomy (LAT)
Number of subjects: 15
Study: 34999670

Group type: EXPERIMENTAL
Intervention: Combined thoracic paravertebral block (TPVB) and general anesthesia
Number of subjects: 86

Group type: COMPARATOR
Intervention: General anesthesia alone
Number of subjects: 86
Study: 33264578

Group type: EXPERIMENTAL
Intervention: Select-by-audiogram
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Select-by-self-test
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Select-by-trying
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Select-by-questionnaire
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Random assignment
Number of subjects: 37

Group type: COMPARATOR
Intervention: NAL-NL2 condition
Number of subjects: 37
Study: 36100964

Group type: EXPERIMENTAL
Intervention: 3-dimensional-printed resection guide
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control (no resection guide)
Number of subjects: 62
Study: 32075569

Group type: EXPERIMENTAL
Intervention: Indwelling urinary catheter (IUC) use within seven days post-randomization
Number of subjects: 11093

Group type: COMPARATOR
Intervention: Control group (no IUC use)
Number of subjects: 11093

Group type: EXPERIMENTAL
Intervention: Indwelling urinary catheter (IUC) use
Number of subjects: 11093
Study: 32945020

Group type: EXPERIMENTAL
Intervention: Removal of falls risk screening tool from falls risk assessment programme
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition with falls risk screening tool
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Removal of falls risk screening tool
Number of subjects: 0
Study: 36430049

Group type: EXPERIMENTAL
Intervention: Maitland mobilization and routine rehabilitation (EG)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Routine rehabilitation (CG)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Sham mobilization and routine rehabilitation (SG)
Number of subjects: 48
Study: 34208055

Group type: EXPERIMENTAL
Intervention: Epinephrine group (125 µg epinephrine)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control group (no epinephrine)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Epinephrine group
Number of subjects: 130
Study: 32627570

Group type: EXPERIMENTAL
Intervention: Multi-component communication intervention including caregiver training and a speech-generating device
Number of subjects: 68
Study: 35329374

Group type: EXPERIMENTAL
Intervention: Two active school-based interventions
Number of subjects: 1974

Group type: COMPARATOR
Intervention: Waiting-list control condition
Number of subjects: 1974
Study: 34062828

Group type: EXPERIMENTAL
Intervention: High-intensity resistance exercise training (HIRT) group (n = 21)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (CG, n = 22)
Number of subjects: 43
Study: 34928408

Group type: EXPERIMENTAL
Intervention: HP‐TDR (high-protein total diet replacement)
Number of subjects: 43

Group type: COMPARATOR
Intervention: CON (control diet)
Number of subjects: 43
Study: 32271243

Group type: EXPERIMENTAL
Intervention: sirolimus‐eluting Orsiro stent
Number of subjects: 2525

Group type: COMPARATOR
Intervention: biolimus‐eluting Nobori stent
Number of subjects: 2525
Study: 36259380

Group type: EXPERIMENTAL
Intervention: Cabozantinib (60 mg/day)
Number of subjects: 258

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: Cabozantinib
Number of subjects: 258
Study: 35010526

Group type: COMPARATOR
Intervention: iSED group
Number of subjects: 245

Group type: COMPARATOR
Intervention: iPA group
Number of subjects: 245
Study: 36037322

Group type: EXPERIMENTAL
Intervention: Metacognitive Training (MCT)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Healthy living skills control group
Number of subjects: 34
Study: 32143721

Group type: EXPERIMENTAL
Intervention: Oral tranexamic acid (TXA) 1950 mg with sublingual misoprostol 800 mcg
Number of subjects: 258

Group type: COMPARATOR
Intervention: Placebo with sublingual misoprostol 800 mcg
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: Both TXA and placebo groups
Number of subjects: 258
Study: 35980238

Group type: EXPERIMENTAL
Intervention: Scotchbond Universal Adhesive (SB; universal) with two coats
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: G Premio Bond (GP; universal) with two coats
Number of subjects: 99

Group type: COMPARATOR
Intervention: Clearfil Megabond 2 (MB; two-step self-etch; control) with two coats
Number of subjects: 99
Study: 34437779

Group type: EXPERIMENTAL
Intervention: Ischemic Preconditioning (IPC)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Sham Treatment
Number of subjects: 14
Study: 32017994

Group type: EXPERIMENTAL
Intervention: IDWL+3 weeks of coaching ('Brief')
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: IDWL+12 weeks of coaching ('Extended')
Number of subjects: 450

Group type: COMPARATOR
Intervention: IDWL only ('Control')
Number of subjects: 450
Study: 34675401

Group type: EXPERIMENTAL
Intervention: High-selenium lentil diet
Number of subjects: 405

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 405
Study: 35387686

Group type: EXPERIMENTAL
Intervention: Diet‐placebo (hypocaloric diet + placebo supplementation)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Diet‐fish (hypocaloric diet + 3 g/day of omega‐3 supplementation)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study: 34418550

Group type: EXPERIMENTAL
Intervention: Withania somnifera (WS)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Hydroxychloroquine (HCQ)
Number of subjects: 400
Study: 36287566

Group type: EXPERIMENTAL
Intervention: Kisspeptin administration (75-minute intravenous infusion of kisspeptin-54 at 1 nmol/kg/h)
Number of subjects: 40
Study: 36469965

Group type: EXPERIMENTAL
Intervention: Targeted gluteal intervention
Number of subjects: 22
Study: 36029059

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sertraline (50 mg/day for 22 weeks)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 60
Study: 33113526

Group type: EXPERIMENTAL
Intervention: 1,000 U/kg Epo intravenously for 6 doses, followed by 400 U/kg Epo subcutaneously 3 times a week through 32 weeks post-menstrual age
Number of subjects: 941

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 941
Study: 36078778

Group type: EXPERIMENTAL
Intervention: Fall prevention program using home floor plans; evaluated effectiveness six months after discharge.
Number of subjects: 60

Group type: COMPARATOR
Intervention: General physiotherapy for disease characteristics; control group treatment before discharge.
Number of subjects: 60
Study: 34021703

Group type: EXPERIMENTAL
Intervention: ET-Score
Number of subjects: 0

Group type: COMPARATOR
Intervention: ML-based scoring functions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Classical scoring functions
Number of subjects: 0
Study: 35734895

Group type: EXPERIMENTAL
Intervention: Leucocyte‐ and platelet‐rich fibrin (L‐PRF) application
Number of subjects: 18

Group type: COMPARATOR
Intervention: Unassisted healing
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: L‐PRF application
Number of subjects: 18
Study: 33644963

Group type: EXPERIMENTAL
Intervention: PNT
Number of subjects: 40

Group type: COMPARATOR
Intervention: PNT + LR-PRP
Number of subjects: 40
Study: 34299891

Group type: EXPERIMENTAL
Intervention: 33-week swimming program
Number of subjects: 22

Group type: COMPARATOR
Intervention: Normal daily activity (Control)
Number of subjects: 22
Study: 32414547

Group type: EXPERIMENTAL
Intervention: Botulinum toxin administered to the levator labii superioris alaeque nasi muscle (Group 1)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Botulinum toxin administered to the orbicularis oris site (Group 2)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 28
Study: 35787043

Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32000853

Group type: EXPERIMENTAL
Intervention: Exposure to risk factors (independent variables such as maternal age, gravidity, parity, antenatal visits, booking status, marital status, educational status, days spent in hospital, mode of delivery, fetal outcomes, and maternal complications)
Number of subjects: 387

Group type: COMPARATOR
Intervention: Control group (women of child-bearing age who survived during the study period)
Number of subjects: 387
Study: 34453675

Group type: EXPERIMENTAL
Intervention: Dabigatran
Number of subjects: 2969

Group type: COMPARATOR
Intervention: Vitamin K antagonist (VKA)
Number of subjects: 2969
Study: 34760995

Group type: EXPERIMENTAL
Intervention: Fan therapy during 6-minute walk test (6MWT)
Number of subjects: 14

Group type: COMPARATOR
Intervention: No fan therapy during 6-minute walk test (6MWT)
Number of subjects: 14
Study: 35984123

Group type: EXPERIMENTAL
Intervention: Oxycodone hydrochloride injection (0.08 mg/kg)
Number of subjects: 0
Study: 34125148

Group type: EXPERIMENTAL
Intervention: New respiratory support system with short binasal prongs (n = 124 infants)
Number of subjects: 246

Group type: COMPARATOR
Intervention: Standard T‐piece system with face mask (n = 122 infants)
Number of subjects: 246
Study: 32340869

Group type: EXPERIMENTAL
Intervention: Chest physiotherapy care-map implemented after the intervention.
Number of subjects: 78

Group type: COMPARATOR
Intervention: Conventional chest physiotherapy before the care-map implementation.
Number of subjects: 78
Study: 35491328

Group type: EXPERIMENTAL
Intervention: Fluoride mouth rinse (FMR) group: 0.2% sodium fluoride mouth rinse plus 1450 ppm fluoride toothpaste
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: High-fluoride toothpaste (HFT) group: 5000 ppm fluoride toothpaste
Number of subjects: 255

Group type: COMPARATOR
Intervention: Control (CTR) group: 1450 ppm fluoride toothpaste
Number of subjects: 255
Study: 32862595

Group type: EXPERIMENTAL
Intervention: etoposide + lobaplatin (EL group)
Number of subjects: 98

Group type: COMPARATOR
Intervention: etoposide + cisplatin (EP group)
Number of subjects: 98
Study: 35987885

Group type: EXPERIMENTAL
Intervention: mirabegron 25 mg once per day for 12 weeks
Number of subjects: 87

Group type: COMPARATOR
Intervention: solifenacin 5 mg once per day for 12 weeks
Number of subjects: 87
Study: 32681995

Group type: EXPERIMENTAL
Intervention: Hysteroscopic morcellation (HM)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Standard resection (SR)
Number of subjects: 90